Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for Primary Central Nervous System Lymphoma
Sites in Burlington +6 more locations
Sponsor: Providence Health & Services
Sex: All·Age: 18+
Code: NCT06175000·Phase 2·Recruiting·Listed Dec 2023